The control of analytical quality of self-monitoring of blood glucose (SMBG) is recommended as a routine procedure in diabetes management. This control procedure should be easily accessible to patients, convenient, not time-consuming, and provide a reliable assessment of glucose meter performance. Optimally it should be located in the diabetes outpatient clinic. Presently there are two approaches to carrying out SMBG quality control. The first is based on the comparison of results obtained by a controlled glucose meter and use of the laboratory method or point-of-care testing device as a surrogate reference analyzer. The second one is a traditionally organized external quality assessment scheme with use of a dedicated control material, which is distributed to all participants. The recommended allowable meter error in SMBG can be realistically set at 10%.
American Diabetes Association Position Statement Standards of Medical Care in Diabetes–2006. Diabetes Care.2006; 29: S4–42.
2.
SacksDBBrunsDEGoldsteinDEMaclarenNKMcDonaldJMParrottM. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem.2002 Mar; 48 (3): 436–72.
3.
American Diabetes Association. Consensus statement on self-monitoring of blood glucose. Diabetes Care.1987; 10: 95–9.
4.
American Diabetes Asociation. Self-monitoring of blood glucose. Diabetes Care.1994; 17: 81–6.
5.
International Organization for Standardization. In vitro diagnostic test systems-Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus. ISO/FDIS 15197 2003.
6.
ClarkeWLCoxDGonder-FrederickLACarterWPohlSL. Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care.1987 Sep-Oct; 10 (5): 622–8.
7.
SolnicaBNaskalskiJWSieradzkiJ. The evaluation of analytical performance of the Precision G point-of-care glucometer. Clin Chem Lab Med.2001 Dec; 39 (12): 1283–6.
8.
SolnicaBNaskalskiJWSieradzkiJ. Analytical performance of glucometers used for routine glucose self-monitoring of diabetic patients. Clin Chim Acta.2003 May; 331 (1–2): 29–35.
9.
GreffkinGWinterWE. Hardware and software in diabetes mellitus: Performance characteristics of hand-held glucose testing devices and the application of glycemic testing to patients' daily diabetes management. Clin Chem.2001 Jan; 47 (1): 11–2.
10.
SkeieSThueGNerhusKSandbergS. Instruments for self-monitoring of blood glucose: Comparisons of testing quality achieved by patients and a technician. Clin Chem.2002 Jul; 48 (7): 994–1003.
11.
DhattG SinghAgarwalMBishawiB. Evaluation of a glucose meter against analytical quality specifications for hospital use. Clin Chim Acta.2004 May; 343 (1–2): 217–21.
12.
HawkinsRC. Evaluation of Roche Accu-Chek Go and Medisense Optium blood glucose meters. Clin Chim Acta.2005 Mar; 353 (1–2): 127–31.
13.
DaiKSTaiDYHoPChenCCPengWCChenSTHsuCCLiuYPHsiehHCYangCCTsaiMCMaoSJ. Accuracy of the EasyTouch blood glucose self-monitoring system: A study of 516 cases. Clin Chim Acta.2004 Nov; 349 (1–2): 135–41.
14.
BoydJCBrunsDE. Quality specifications for glucose meters: Assessment by simulation modeling of errors in insulin dose. Clin Chem.2001 Feb; 47 (2): 209–14.
15.
SkeieSThueGSandbergS. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose. Clin Chem.2001 Jan; 47 (1): 67–73.
16.
American Diabetes Association Position Statement. Diagnosis and classification of diabetes mellitus. 2004. Diabetes Care.2006; 29: S43–8.
17.
SolnicaBNaskalskiJW. Quality control of SMBG in clinical practice. Scand J Clin Lab InvestSuppl.2005; 240: 80–5.
18.
LefevreGGirardot-DuboisSChevallierGCohenCCoudercREtienneJ. Evaluation of the quality of blood glucose meters using the HemoCue B glucose system. Diabetes Metab.1999 Sep; 25 (4): 350–5.
19.
International Federation of Clinical Chemistry and Laboratory Medicine, Scientific Division, Working Group on Selective Electrodes. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta.2001; 307: 205–9.
20.
KristensenGBNerhusKThueGSandbergS. Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose. Clin Chem.2006 Jul; 52 (7): 1311–7.
21.
WoodWG. Problems with the external quality assessment of accuracy of point of care devices (POCD) for blood glucose are independent of sample composition. Clin Lab.2006; 52 (7–8): 345–51.
22.
GuerciBDrouinPGrangeVBougneresPFontainePKerlanVPassaPThivoletChVialettesBCharbonnelB; ASIAGroup. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: The Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab.2003 Dec; 29 (6): 587–94.
23.
WinterWE. A Rosetta stone for insulin treatment: Self-monitoring of blood glucose. Clin Chem.2004 Jun; 50 (6): 985–7.
